Target intelligence / Profile preview

Large intestine mucosa

Molecular classification
Other
01

Overview

The large intestine mucosa is the innermost tissue layer of the colon and rectum, playing a vital role in the final stages of digestion and waste elimination. It is composed of a simple columnar epithelium, a supporting lamina propria containing immune cells, and a thin layer of smooth muscle known as the muscularis mucosae (StatPearls, 2023). Its primary biological functions include the absorption of water and electrolytes, the secretion of mucus to facilitate fecal passage, and acting as a robust immunological barrier against luminal pathogens and microbiota (NIH, 2024). In the context of pharmacology, the mucosa is the primary site of pathology for conditions such as ulcerative colitis, Crohn's disease, and colorectal cancer (PubMed, 2021). While many therapeutic agents are delivered to or act within this tissue, the mucosa itself is an anatomical structure rather than a specific molecular target. Drugs targeting this region typically interact with specific receptors, enzymes, or cytokines, such as tumor necrosis factor (TNF) or alpha-4 beta-7 integrin, located within the mucosal environment (PubChem, 2024). Consequently, Large intestine mucosa is considered a site of action or a tissue-level target rather than a discrete molecular entity.

Other names
Colonic mucosaRectal mucosaIntestinal mucous membraneMucosa of large intestine
02

Mechanism of action

Not applicable as this is an anatomical tissue layer rather than a specific molecular target. Therapeutic agents acting within this tissue target specific proteins such as cytokines, integrins, or enzymes.

03

Biological functions

Barrier functionWater absorptionElectrolyte transportMucus secretionImmune surveillance
04

Disease associations

Ulcerative colitisCrohn's diseaseColorectal cancerIrritable bowel syndromeInfectious colitis
05

Safety considerations

Mucosal atrophyIncreased intestinal permeabilityRisk of opportunistic infectionsGastrointestinal bleeding
06

Interacting drugs

Mesalamine

4 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal lactoferrinC-reactive protein

Beyond the preview

Go deeper on Large intestine mucosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Large intestine mucosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call